DocGo Newsroom

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), DocGo (DCGO) and Alkermes (ALKS)

TipRanksDec 6 02:08

Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8

Futu NewsDec 6 01:31

Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 11 22:33

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and DocGo (DCGO)

TipRanksNov 11 20:05

Deutsche Bank Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $5

Futu NewsNov 8 23:31

Stifel Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $6.5

Futu NewsNov 8 23:31

Analysts' Top Healthcare Picks: DocGo (DCGO), Resmed (RMD)

TipRanksNov 8 19:33

Needham Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 8 19:31

Analysts' Top Healthcare Picks: DocGo (DCGO), Avidity Biosciences (RNA)

TipRanksOct 4 19:35

Stifel Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $6.5

Futu NewsOct 4 19:34

Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8

Futu NewsAug 23 21:32

Northland Securities Sticks to Its Buy Rating for DocGo (DCGO)

TipRanksAug 23 20:57

DocGo Analyst Ratings

BenzingaAug 20 22:39

Cantor Fitzgerald Reiterates Overweight on DocGo, Maintains $5 Price Target

BenzingaAug 20 22:39

Northland Securities Remains a Buy on DocGo (DCGO)

TipRanksAug 8 22:13

Buy Rating Affirmed for DocGo on Strong Quarterly Performance and Positive Growth Trajectory

TipRanksAug 8 20:54

Analysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and DocGo (DCGO)

TipRanksAug 8 18:13

DocGo Price Target Maintained With a $7.00/Share by Needham

Dow JonesAug 8 18:12

DocGo Analyst Ratings

BenzingaAug 8 17:57

Needham: Maintaining the DoCGO (DCGO.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $10.00 to $7.00.

Zhitong FinanceMay 10 01:31